Article
Impact of BRAF V600E Mutation on Surgical Management and Outcomes in Low-Risk Differentiated Thyroid Carcinoma (T1–2N0M0)
2026-05-18
Abstract excerpt
<title>Abstract</title> <p>Background The clinical relevance of the BRAF V600E mutation in the surgical management of early-stage differentiated thyroid carcinoma (DTC) remains unclear. Although common in papillary thyroid carcinoma, its role in guiding surgical decisions in low-risk disease is still debated. Methods We conducted a retrospective single-center study of patients with low-risk DTC (T1–2N0M0) treat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 79236d3e-b392-5b7b-9b16-459edf5c560e
- DOI
- 10.21203/rs.3.rs-9407674/v1
